Keyword Analysis & Research: watchman device anticoagulation guidelines


Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
watchman device anticoagulation guidelines0.10.711254642
watchman0.180.28363538
device1.750.8667366
anticoagulation1.370.392662715
guidelines0.03122311310

Keyword Research: People who searched watchman device anticoagulation guidelines also searched

Keyword CPC PCC Volume Score
watchman device anticoagulation guidelines1.440.4766290
anticoagulation after watchman device0.760.2269997
anticoagulation after watchman guidelines1.790.7321221
watchman device vs anticoagulation0.190.8796079
watchman procedure and anticoagulation1.840.1623121
anticoagulation after watchman procedure1.27118683
anticoagulation post watchman procedure1.990.1558956
post watchman anticoagulation regimen1.890.1271326
how long anticoagulation after watchman1.10.616614
watchman procedure for afib anticoagulation0.790.271456
do you need anticoagulation after watchman0.180.6258912
how long to anticoagulate after watchman0.290.9101764
guidelines for watchman device1.80.8925251
watchman device indications acc1.130.18442
contraindications to watchman device1.220.9290085
watchman device prevent clots valvular afib0.720.4412411
watchman patient information guide0.040.4116494
watchman blood clot device1.20.5988040
anticoagulation clinical practice guidelines1.260.8790227
watchman clinical trial protocol0.020.9163269
watchman procedure patient information pdf0.790.8954461

Search Results related to watchman device anticoagulation guidelines on Search Engine

  • The WATCHMAN device and post-implantation anticoagulation …

    nih.gov

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784674/

    WEBDec 15, 2021 · Anticoagulation is the gold standard to prevent stroke and systemic embolization. However, many patients have a contraindication to oral anticoagulation. The WATCHMAN device, which closes the left atrial appendage, is non-inferior to warfarin to prevent embolic events in clinical trials.

    DA: 46 PA: 6 MOZ Rank: 55

  • 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline …

    ahajournals.org

    https://www.ahajournals.org/doi/10.1161/CIR.0000000000000665

    WEBLeft atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).

    DA: 99 PA: 11 MOZ Rank: 2

  • Antithrombotic Management After Left Atrial Appendage Closure: …

    ahajournals.org

    https://www.ahajournals.org/doi/10.1161/CIRCINTERVENTIONS.122.012812

    WEBMay 16, 2023 · Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry.

    DA: 67 PA: 37 MOZ Rank: 35

  • Anticoagulation Management After Watchman Implantation

    citoday.com

    https://citoday.com/articles/2017-may-june/anticoagulation-management-after-watchman-implantation

    WEBIn the largest randomized controlled trials comparing either LAA closure with the Watchman device or warfarin therapy in patients eligible for long-term OAT (the PROTECT AF and PREVAIL studies 3,4 ), it was recommended to give aspirin (81–325 mg) indefinitely with warfarin for 45 days.

    DA: 8 PA: 10 MOZ Rank: 63

  • Atrial fibrillation: Left atrial appendage occlusion - UpToDate

    uptodate.com

    https://www.uptodate.com/contents/atrial-fibrillation-left-atrial-appendage-occlusion

    WEBFeb 24, 2023 · Whereas anticoagulation is recommended for most patients with AF, some patients have contraindications to long-term anticoagulation. Anticoagulation in patients with AF is discussed separately. (See "Atrial fibrillation in adults: Selection of candidates for anticoagulation" and "Atrial fibrillation in adults: Use of oral anticoagulants" .)

    DA: 66 PA: 98 MOZ Rank: 97

  • Antithrombotic Therapy After Left Atrial Appendage Occlusion

    acc.org

    https://www.acc.org/latest-in-cardiology/journal-scans/2022/05/04/18/19/antithrombotic-therapy-after-laao

    WEBMay 4, 2022 · The Watchman LAAO device offers significant stroke prevention for patients who are at risk of bleeding complications associated with anticoagulant use. However, in the pivotal trials, patients were discharged on warfarin plus aspirin for 45 days, after which they typically continued on DAPT until 6 months.

    DA: 59 PA: 77 MOZ Rank: 5

  • Left Atrial Appendage Occlusion - American College of Cardiology

    acc.org

    https://www.acc.org/latest-in-cardiology/articles/2017/01/31/13/08/left-atrial-appendage-occlusion

    WEBJan 31, 2017 · The patients need to be on warfarin for at least 45 days post-WATCHMAN. This regimen was chosen to allow for device endothelialization. Patients can then be switched to clopidogrel and aspirin (for another 4.5 months and then aspirin 325 mg indefinitely thereafter) if the residual leak on transesophageal echocardiography at 45 …

    DA: 50 PA: 10 MOZ Rank: 82

  • Antithrombotic Therapy After Left Atrial Appendage Occlusion in

    jacc.org

    https://www.jacc.org/doi/10.1016/j.jacc.2022.02.047

    WEBMay 2, 2022 · COMPETENCY IN PATIENT CARE AND PROCEDURAL SKILLS: In a registry of patients with AF undergoing LAAO with the Watchman device, postprocedural anticoagulation with warfarin or a target-specific oral agent (DOAC) without concomitant aspirin was associated with lower risk of adverse outcomes.

    DA: 34 PA: 45 MOZ Rank: 1

  • EWOLUTION of Watchman Left Atrial Appendage Closure to …

    ahajournals.org

    https://www.ahajournals.org/doi/10.1161/CIRCEP.119.007257

    WEBApr 3, 2019 · Oral anticoagulation (OAC) use using vitamin K (VKAs) or a non-VKA is a class I recommendation for stroke prevention in atrial fibrillation (AF) and a CHA 2 DS 2 -VASc score ≥2 for men and ≥3 for women. 1 Despite the clinical efficacy, many patients with AF have relative or absolute contraindications for long-term OAC because of perceived …

    DA: 44 PA: 49 MOZ Rank: 68

  • Indications for use WATCHMANTM - Boston Scientific

    bostonscientific.com

    https://www.bostonscientific.com/content/dam/bostonscientific/Rhythm%20Management/portfolio-group/WATCHMAN/download-center/product-info/SH-367707-AA_ReferringPhysicianBrochure.pdf

    WEBThe WATCHMAN Device is indicated to reduce the risk of thromboembolism from the left atrial appendage in patients with non-valvular atrial fibrillation who: • Are at increased risk for stroke and systemic embolism based on CHADS2 or CHA2DS2-VASc scores and are recommended for anticoagulation therapy; • Are deemed by their physicians to be …

    DA: 68 PA: 9 MOZ Rank: 65